Skip to main content
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1960;23(1):47–52.

Experiments with Vi-negative strains of Salmonella typhi

A F B Standfast
PMCID: PMC2555310  PMID: 13833749

Abstract

The immunological properties of a number of strains of Salmonella typhi were tested. One of these strains, although it did not contain the Vi antigen, was able to protect the mice against Vi-positive challenge when used as a vaccine for mice. The finding of a stable Vi-negative strain is important, as many strains, such as the classic O 901, revert to the Vi-positive state on a single mouse passage.

Using the Vi-negative organism as challenge in eight assays of the vaccines used in the Yugoslav field studies at Osijek, the phenolized vaccine was shown to be about 10 times more potent than the alcoholized vaccine. Further laboratory tests in conjunction with field trials will be necessary to show if these results are significant.

Full text

PDF
47

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BATSON H. C. The relative significance of graded immunizing and challenge doses in measuring the potency of vaccines; a study of mouse protection by typhoid vaccine. J Exp Med. 1949 Sep;90(3):233–253. doi: 10.1084/jem.90.3.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. EDSALL G., CARLSON M. C., FORMAL S. B., BENENSON A. S. Laboratory tests of typhoid vaccines used in a controlled field study. Bull World Health Organ. 1959;20:1017–1032. [PMC free article] [PubMed] [Google Scholar]
  3. FELIX A. The preparation, testing and standardization of typhoid vaccine. J Hyg (Lond) 1951 Jun-Sep;49(2-3):268–297. doi: 10.1017/s0022172400044156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Grinnell F. B. A STUDY OF THE DISSOCIATION OF THE RAWLINS STRAIN OF BACTERIUM TYPHOSUM WITH SPECIAL REFERENCE TO ITS USE IN THE PRODUCTION OF ANTI-TYPHOID VACCINE. J Exp Med. 1932 Nov 30;56(6):907–918. doi: 10.1084/jem.56.6.907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. LANDY M., GAINES S., SPRINZ H. Studies on intracerebral typhoid infection in mice. II. Immunological factors concerned in protection. Br J Exp Pathol. 1957 Feb;38(1):25–34. [PMC free article] [PubMed] [Google Scholar]
  6. LANDY M., JOHNSON A. G., WEBSTER M. E., SAGIN J. F. Studies on the O antigen of Salmonella typhosa. II. Immunological properties of the purified antigen. J Immunol. 1955 Jun;74(6):466–478. [PubMed] [Google Scholar]
  7. MILLER W. S., CLARK D. L., DIERKHISING O. C. A laboratory comparison of United States and British army typhoid-paratyphoid vaccine. Am J Trop Med Hyg. 1951 Sep;31(5):535–551. doi: 10.4269/ajtmh.1951.s1-31.535. [DOI] [PubMed] [Google Scholar]
  8. PILLEMER L., BLUM L., LEPOW I. H., ROSS O. A., TODD E. W., WARDLAW A. C. The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science. 1954 Aug 20;120(3112):279–285. doi: 10.1126/science.120.3112.279. [DOI] [PubMed] [Google Scholar]
  9. ROWLEY D. Stimulation of natural immunity to Escherichia coli infection: observations on mice. Lancet. 1955 Jan 29;268(6857):232–234. doi: 10.1016/s0140-6736(55)90163-x. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES